Stereotactic body radiotherapy to the lung primary lesion improves the survival of patients with non-oligometastatic NSCLC harboring EGFR activating mutation with first-line EGFR-TKIs: A real-world study.

ANNALS OF ONCOLOGY（2021）

引用 0|浏览7

暂无评分

关键词

stereotactic body radiotherapy,lung,mutation,non-oligometastatic,first-line,egfr-tkis,real-world

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要